微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 47.7% | 15.29% | -5.74% | 78/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 50.61% | 25.92% | 17.68% | 74/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 43.01% | 3.9% | 1.72% | 85/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 42.28% | 5.59% | 2.18% | 85/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 41.38% | 5.34% | 2.96% | 86/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 40.19% | 3.31% | -2.91% | 90/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 41.39% | 3.94% | 3.37% | 94/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 40.04% | 1.51% | 1.94% | 94/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 39.28% | -0.27% | 0.98% | 99/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 38.9% | -0.42% | -2.32% | 92/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 39.83% | 7.05% | 0.96% | 99/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 39.45% | 0.95% | 0.15% | 94/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 39.39% | -2.12% | 0.82% | 96/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 39.07% | -6.36% | 5.01% | 92/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 37.2% | -8.87% | -4.79% | 104/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 39.07% | -7.17% | -2.9% | 94/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 40.24% | -7.83% | -3.54% | 97/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 41.72% | -10.29% | 2.19% | 83/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 40.82% | -12.79% | -3.01% | 103/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 42.09% | -13.23% | -3.59% | 88/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 43.66% | -13.6% | -6.12% | 93/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 46.5% | -1.25% | -0.66% | 76/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 46.81% | 7.86% | -3.51% | 96/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 48.51% | 11.62% | -3.99% | 68/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 50.53% | 14.63% | 7.3% | 80/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 47.09% | 10.05% | 8.51% | 52/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 43.4% | 6.76% | -0.14% | 88/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 43.46% | -0.27% | -1.4% | 47/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 44.08% | -0.91% | 3.01% | 53/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 42.79% | -7.38% | 5.26% | 31/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 40.65% | -8.99% | -6.71% | 81/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 43.58% | -3.6% | -2.03% | 31/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 44.48% | -6.82% | -3.72% | 36/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 46.2% | -2.36% | 3.43% | 27/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 44.67% | -4.02% | -1.18% | 68/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 45.2% | -0.45% | -5.3% | 25/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 47.73% | 6.13% | 0.88% | 33/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 47.32% | 6.09% | 1.68% | 25/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 46.54% | 7.16% | 2.48% | 51/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 45.41% | 5.9% | 0.96% | 21/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 44.98% | 5.54% | 0.85% | 27/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 44.6% | -2.67% | 2.7% | 18/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |